RCT Comparing the DEXA Results of the HA-Omnifit Versus the Symax Uncemented Hip Stem

September 25, 2012 updated by: Maastricht University Medical Center

A Randomized Comparative Study to Evaluate the Performance and Confirm the Safety of the Diocom Hip Syhstem in Cementless Hip Arthroplasty

Thr purpose of this study is to compare the clinical and radiological results, as well as the femur bone density measurements of two uncemented total hip prostheses during 5 years of follow up.

Study Overview

Detailed Description

It is of great importance for the function of uncemented total hip arthroplasty that the anchorage of the prosthesis in the bone of the femur is sufficient. This is of great importance in the prevention of stress shielding of the bone and to insure tranfer of forces from the prosthesis to the femur.

The symax hip stem is developed to optimize stress tranfer to bone and insure mechanical stability.

In this study the symax hip stem is compared to the HA_Omnifit hip stem (a frequently used and long term evaluated uncemented hip prosthesis) During the fist two years of follow up DEXA mesurments of bone mineral density are performed. Also patient satisfaction, patient fuction score and radiological evaluation measurements are done during 5 years of follow up.

Our primary objective is: comparison of the short term bone remodelling surrounding the Symax hip stem to the short term remodeling surrounding the Stryker Omnifit HA hip stem measured by bone densitometry, clinical and radiographic evaluation.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:Male or non pregnant female patients >18 years

  • Patient with degenerative or traumatic changes to hip requiring hip replacement
  • Patient with BMI<35
  • Patient signed informed consent

Exclusion Criteria:

  • chronic anti-inflammatory medication use> 3 months
  • revision surgery to the affected femur
  • Cancer therapy including immunosuppression, chemotherapy and radiation
  • Pathological fractures, delayed ossification or non-union is likely to occur

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: HA-Omnifit
Patients who receive a HA-Omnifit uncemented hip stem
Active Comparator: Symax hip stem
Patients with the Symax uncemented hip stem

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
short term bone remodeling
Time Frame: 6 times within 2 years
Bone remodeling is determined by measuring the Bone mineral density during time
6 times within 2 years
complications and reoperations
Time Frame: during 5 years
Reporting all complications and reoperations of the two different hip prostheses
during 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
clinical performance
Time Frame: 9 times within 5 years
Comparison of the clinical performance of the two different hip prostheses
9 times within 5 years
Radiological evaluation
Time Frame: 9 times within 5 years
Evaluation of Xrays according to the engh classifications
9 times within 5 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient satisfaction
Time Frame: 9 times within 5 years
comparison of patient satisfaction between the two different prostheses
9 times within 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lodewijk van Rhijn, azM

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2003

Primary Completion (Actual)

July 1, 2009

Study Completion (Actual)

July 1, 2009

Study Registration Dates

First Submitted

September 25, 2012

First Submitted That Met QC Criteria

September 25, 2012

First Posted (Estimate)

September 27, 2012

Study Record Updates

Last Update Posted (Estimate)

September 27, 2012

Last Update Submitted That Met QC Criteria

September 25, 2012

Last Verified

September 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • Symax DEXA study
  • MEC 02-072 (Other Identifier: METC MUMC Maastricht)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients With Osteoarthritis of the Hip Joint Elligable for a Uncemented Hipprosthesis

Clinical Trials on uncemented total hip arthroplasty

3
Subscribe